Soligenix, Inc. (SNGX)
NASDAQ: SNGX · Real-Time Price · USD
0.410
+0.015 (3.80%)
At close: Jun 26, 2026, 4:00 PM EDT
0.395
-0.015 (-3.66%)
After-hours: Jun 26, 2026, 7:49 PM EDT
Soligenix Employees
As of December 31, 2025, Soligenix had 14 total employees, including 13 full-time and 1 part-time employees. The number of employees decreased by 2 or -12.50% compared to the previous year.
Employees
14
Change (1Y)
-2
Growth (1Y)
-12.50%
Revenue / Employee
n/a
Profits / Employee
-$782,434
Market Cap
6.08M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| BioAtla | 41 |
| NextCure | 40 |
| Aptevo Therapeutics | 33 |
| Cardio Diagnostics Holdings | 17 |
| NuCana | 12 |
| XTL Biopharmaceuticals | 10 |
| Purple Biotech | 10 |
| CNS Pharmaceuticals | 8 |
SNGX News
- 18 days ago - Soligenix to apply for vaccine development funding for Bundibugyo Ebola vaccine - TheFly
- 18 days ago - Soligenix Applying for Vaccine Development Funding for Bundibugyo Ebola Vaccine - PRNewsWire
- 4 weeks ago - Suitability of Vaccine Platform for Bundibugyo Virus, Cause of the Ebola Outbreak in Congo - PRNewsWire
- 7 weeks ago - Soligenix reports Q1 EPS (28c) vs. (97c) last year - TheFly
- 7 weeks ago - Soligenix Announces Recent Updates and First Quarter 2026 Financial Results - PRNewsWire
- 7 weeks ago - Soligenix Quarterly report: Q1 2026 - Filings
- 7 weeks ago - Soligenix Earnings release: Q1 2026 - Filings
- 7 weeks ago - Soligenix price target lowered to $1.50 from $10 at Alliance Global - TheFly